Pfizer: Albert Bourla
When Ian Read steps down, Albert Bourla will take his place as the next CEO of Pfizer.
Bourla has worked at Pfizer for 25 years, after joining in 1993 as the technical director for the company’s animal division in Greece.
He began work in the headquarters within the animal health division, which has since been spun out, before stepping into a succession of roles that led him to be COO in January 2018. One of those roles was leading Pfizer’s Innovative Health business that brought in $34bn (€29.5bn) in revenue.
Shantanu Narayan said in a statement, “Today’s leadership announcement [appointing Bourla] is part of a thoughtful, multi-year succession planning process.”
